BioSensics

BioSensics is a medical device company founded in 2007 by three Harvard University scientists, specializing in wearable sensor technologies and digital health platforms for clinical trials and patient monitoring. The company focuses on developing validated digital biomarkers and outcome assessment tools, particularly for neurological and rare disorders.

The company provides end-to-end support for clinical studies through its BioDigit Cloud platform, offering study management, data quality monitoring, device provisioning, and technical consulting services. BioSensics applies machine learning, AI, and statistical modeling to collect and analyze digital health data, enabling objective measurement of disease symptoms and patient compliance throughout clinical trials.

With over 17 years of research experience, BioSensics has established partnerships with major academic medical centers including Johns Hopkins, Vanderbilt, and Baylor College of Medicine, as well as disease advocacy organizations focused on conditions such as ALS, muscular dystrophy, and Friedreich's ataxia.

BioSensics excels in scenarios where clinical trials require validated wearable sensors and digital biomarkers, particularly for conditions affecting movement, balance, and neurological function. Their academic pedigree and research institution partnerships make them well-suited for early-phase studies and novel biomarker development.

Expect a research-driven approach with access to the BioDigit Cloud platform for centralized data collection and real-time compliance monitoring. The company provides dedicated project management and technical support throughout the study lifecycle, suitable for sponsors seeking a comprehensive technology and services partner rather than just device procurement.

BioSensics operates exclusively in healthcare, developing FDA-regulated wearable medical devices and supporting clinical research. Their portfolio specifically targets clinical trials and patient monitoring for conditions including myasthenia gravis, ALS, muscular dystrophy, Friedreich's ataxia, and other neurological disorders.

The company's healthcare focus extends through partnerships with disease advocacy groups and academic medical centers, positioning them within the clinical research ecosystem rather than consumer health. Their BioDigit Cloud platform is designed for compliant clinical data collection and management, supporting regulatory requirements for medical device studies and pharmaceutical trials.

Pharmaceutical and biotechnology companies developing therapies for neurological conditions, rare diseases, or movement disorders who need objective, sensor-based outcome measures. Research institutions conducting observational studies or early-phase trials requiring wearable technology infrastructure. Medical device companies seeking co-development partners with expertise in sensor validation and regulatory pathways for digital health technologies.